Biologic incorporation of allograft anterior cruciate ligament replacements

Soft tissue allografts allow the orthopaedic surgeon to reconstruct ligaments without having to harvest additional tissue from the patient, which can eliminate donor tissue site morbidity and reduce surgical time. There is still much to be learned about the biologic aspects of the remodeling and incorporation of allografts in comparison with autografts. The interaction of cells, matrix, and biomolecules, such as growth factors, plays an important role that can potentially modulate, enhance, or impede the healing response in allografts. The authors have shown that, in the short term, allografts used in anterior cruciate ligament reconstruction are not as rapidly remodeled and incorporated into host tissue as are autografts. The long-term implications of this slower allograft incorporation in anterior cruciate ligament reconstruction are still unknown. The cells that repopulate allografts and autografts favor production of smaller diameter collagen fibrils, which in sufficient numbers can provide significant strength. Use of allografts raises other issues and potential disadvantages, including scarcity, immunogenicity, the potential for disease transmission, and cost-effectiveness in anterior cruciate ligament reconstruction.